Clinical Trial

Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis

Study acronym: PAVE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigation aims to demonstrate initial safety and efficacy of the AngioVac System for the removal of vegetation in the right heart in patients with infective endocarditis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-11.
Trial Details
NCT Number NCT07282002
Lead Sponsor Angiodynamics, Inc.
Conditions Infective Endocarditis (IE)
Enrollment 30 participants
Start Date 2026-04
Primary Completion 2026-11 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-22